Back to Search
Start Over
Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
- Source :
- Lipids in Health and Disease
- Publication Year :
- 2014
-
Abstract
- Background Lipoprotein associated phospholipase A2 (Lp-PLA2) is a novel biomarker for cardiovascular risk prediction. Whether increased Lp-PLA2 level is associated with re-stenosis after stent-placement is unclear. Methods Totally 326 participants eligible for stent-placement were enrolled and divided into two groups according to baseline Lp-PLA2 levels (named normal and elevated groups). Baseline characteristics and clinical outcomes were compared between normal and elevated groups. The relationships between Lp-PLA2 and other risk factors with re-stenosis were evaluated. Results Only the between-group difference of Lp-PLA2 was significant (123.2 ± 33.6 ng/mL vs 336.8 ± 85.4 ng/mL, P
- Subjects :
- Male
Acute coronary syndrome
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
Clinical Biochemistry
Clinical nutrition
Coronary Artery Disease
Gastroenterology
Percutaneous coronary intervention
Coronary artery disease
Coronary Restenosis
Lipoprotein associated phospholipase A2
Endocrinology
Risk Factors
Internal medicine
medicine
Humans
Aged
Proportional Hazards Models
Biochemistry, medical
Proportional hazards model
business.industry
Incidence (epidemiology)
Lipoprotein-associated phospholipase A2
Research
Biochemistry (medical)
Hazard ratio
Middle Aged
medicine.disease
Treatment Outcome
1-Alkyl-2-acetylglycerophosphocholine Esterase
Multivariate Analysis
Cardiology
lipids (amino acids, peptides, and proteins)
Female
Stents
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 1476511X
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Lipids in health and disease
- Accession number :
- edsair.doi.dedup.....5e7c91883a1efa98cf17ab2532508c85